London Daily

Focus on the big picture.
Sunday, Jul 06, 2025

UK pauses AstraZeneca Covid-19 vaccine study on children as drug regulator investigates blood clot risk among adults

UK pauses AstraZeneca Covid-19 vaccine study on children as drug regulator investigates blood clot risk among adults

A trial of the Oxford/AstraZeneca Covid-19 vaccine on children has been suspended while the UK’s drug regulator investigates a potential link to rare blood clots in the brain reported among some adults who have received the jab.
The vaccine, which was developed in partnership with Oxford University, is awaiting approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for use among children. It was greenlit by British regulators for use in adults at the end of 2020.

“Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial,” a University of Oxford spokesperson told British media on Tuesday.

The trial of the vaccine on children aged between six and 17 began in February and is the first of its kind to test the jab’s ability to generate an immune response in the under-18s.

Reports have surfaced in recent weeks of blood clot incidents among a very small number of people who received a dose of the AstraZeneca vaccine in the days before their illness, though no clear causal link has been established between the clots and the inoculation. The EU’s drugs regulator, the European Medicines Agency (EMA), said last month that the benefits of the jab outweigh its risks after a number of member states paused their rollouts of the vaccine after reports of blood clots.

Following the regulator’s opinion, many states resumed their use of the vaccine, while investigations by the EMA’s safety committee into a causal link between the jab and rare blood clots continued.

Fresh updates from the MHRA and the EMA about the use of the drug are expected in the next few days. The EMA said it expects its committee to issue an update on the jab this week, but the regulator’s head of vaccines strategy, Marco Cavaleri, on Tuesday suggested that the vaccine is linked to blood clotting.

Although governments resumed their rollout of the vaccine, some countries imposed age restrictions on its use, due to the apparent higher prevalence of blood clots in younger people who had received it.
Germany’s medicines regulator limited it for use in people aged under 60, while Canada paused its rollout to those under 55. France has limited the jab for those under 55, and last month Denmark extended its suspension of the vaccine for three weeks.
Newsletter

Related Articles

0:00
0:00
Close
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
Poland Implements Border Checks Amid Growing Migration Tensions
Political Dispute Escalates Between Trump and Musk
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
US Senate Votes to Remove AI Regulation Moratorium from Domestic Policy Bill
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
Jury Deliberations in Diddy Trial Yield Partial Verdict in Serious Criminal Charges
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
King Charles Plans Significant Role for Prince Harry in Coronation
Two Chinese Nationals Arrested for Espionage Activities Against U.S. Navy
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
×